SQL
(6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene
Find entries where: SQL
is present as a standalone ligand in 7 entries
Chemical Component Summary | |
---|---|
Name | (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene |
Synonyms | squalene |
Identifiers | (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene |
Formula | C30 H50 |
Molecular Weight | 410.718 |
Type | NON-POLYMER |
Isomeric SMILES | CC(=CCC/C(=C/CC/C(=C/CC/C=C(/CC/C=C(/CCC=C(C)C)\C)\C)/C)/C)C |
InChI | InChI=1S/C30H50/c1-25(2)15-11-19-29(7)23-13-21-27(5)17-9-10-18-28(6)22-14-24-30(8)20-12-16-26(3)4/h15-18,23-24H,9-14,19-22H2,1-8H3/b27-17+,28-18+,29-23+,30-24+ |
InChIKey | YYGNTYWPHWGJRM-AAJYLUCBSA-N |
Chemical Details | |
---|---|
Formal Charge | 0 |
Atom Count | 80 |
Chiral Atom Count | 0 |
Bond Count | 79 |
Aromatic Bond Count | 0 |
Drug Info: DrugBank
DrugBank ID | DB11460 |
---|---|
Name | Squalene |
Groups |
|
Description | Squalene is originally obtained from shark liver oil. It is a natural 30-carbon isoprenoid compound and intermediate metabolite in the synthesis of cholesterol. It is not susceptible to lipid peroxidation and provides skin protection. It is ubiquitously distributed in human tissues where it is transported in serum generally in association with very low density lipoproteins. Squalene is investigated as an adjunctive cancer therapy. |
Synonyms |
|
Brand Names |
|
Categories |
|
CAS number | 111-02-4 |
Related Resource References
Resource Name | Reference |
---|---|
PubChem | 638072 |
ChEMBL | CHEMBL458402 |
ChEBI | CHEBI:15440 |